COMPARATIVE PHARMACOKINETICS OF 2 DIASTEREOISOMERS DEXAMETHASONE AND BETAMETHASONE IN PLASMA AND CEREBROSPINAL-FLUID IN RABBITS

被引:24
|
作者
TRENQUE, T [1 ]
LAMIABLE, D [1 ]
VISTELLE, R [1 ]
MILLART, H [1 ]
LEPERRE, A [1 ]
CHOISY, H [1 ]
机构
[1] UFR PHARM,PHARMACOL LAB,F-51096 REIMS,FRANCE
关键词
DEXAMETHASONE; BETAMETHASONE; PLASMA; CSF; RABBIT;
D O I
10.1111/j.1472-8206.1994.tb00822.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The two diastereoisomers dexamethasone (DXM) and betamethasone (BTM) were infused at two different doses (2, 10 mg.kg(-1)) in anesthetized rabbits. Samples of plasma and cerebrospinal fluid were collected over a 180-min period. Steroid concentrations were measured by high performance liquid chromatography. The terminal half life (85.7 +/- 20.8 min and 102.2 +/- 29.6 min for DXM; 117.6 +/- 19.8 min and 118.5 +/- 15.8 min for BTM) and the mean residence time (121.4 +/- 27.7 min and 146.1 +/- 41.3 min for DXM; 168.6 +/- 28.1 min and 172.2 +/- 20.6 min for BTM) were unchanged between the doses. Dose-dependent changes in the area under the curve normalized by the dose, then volume distribution and clearance were observed. The average percentage of DXM and BTM bound to plasma proteins were 78.1 +/- 11.5% and 88.3 +/- 5.1% respectively at the lower dose, and decreased significantly with 10 mg.kg(-1). DXM appeared more rapidly in the CSF, the highest concentrations of DXM were obtained within 15 min after the end of the injection. The CSF levels were lower than that of plasma unbound and the passage through the blood-brain barrier was saturable. These results will complicate pharmacokinetic and pharmacodynamic analysis.
引用
收藏
页码:430 / 436
页数:7
相关论文
共 50 条
  • [1] THE PHARMACOKINETICS OF ISONIAZID AND HYDRAZINE METABOLITE IN PLASMA AND CEREBROSPINAL-FLUID OF RABBITS
    WALUBO, A
    CHAN, K
    WONG, CL
    [J]. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1991, 13 (03): : 199 - 204
  • [2] PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF 5-AZA-2'-DEOXYCYTIDINE IN RABBITS AND DOGS
    CHABOT, GG
    RIVARD, GE
    MOMPARLER, RL
    [J]. CANCER RESEARCH, 1983, 43 (02) : 592 - 597
  • [3] DISPOSITION OF ETHMOZINE IN CEREBROSPINAL-FLUID AND PLASMA OF RABBITS
    CHAN, K
    YANG, JM
    WAI, MK
    JIANG, WD
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1989, 14 (04) : 279 - 282
  • [4] PHARMACOKINETICS OF DIMINAZENE IN PLASMA AND CEREBROSPINAL-FLUID OF GOATS
    MAMMAN, M
    PEREGRINE, AS
    [J]. RESEARCH IN VETERINARY SCIENCE, 1994, 57 (02) : 253 - 255
  • [5] PHARMACOKINETICS OF MORPHINE IN CEREBROSPINAL-FLUID AND PLASMA OF DOGS
    RIGEL, EP
    HUG, CC
    [J]. PHARMACOLOGIST, 1976, 18 (02): : 120 - 120
  • [6] TOLOXATONE PHARMACOKINETICS IN THE PLASMA AND CEREBROSPINAL-FLUID OF THE RABBIT
    VISTELLE, R
    LAMIABLE, D
    ZINSOU, M
    LEON, A
    WICZEWSKI, M
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 (02) : 124 - 126
  • [7] COMPARATIVE PHARMACOKINETICS OF D-ALPHAMETHYLDOPA AND L-ALPHAMETHYLDOPA IN PLASMA, AQUEOUS-HUMOR, AND CEREBROSPINAL-FLUID IN RABBITS
    AUCLAIR, E
    LAUDE, D
    WAINER, IW
    CHAOULOFF, F
    ELGHOZI, JL
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1988, 2 (04) : 283 - 293
  • [8] CEFUROXIME - PHARMACOKINETICS IN COCHLEAR PERILYMPH, CEREBROSPINAL-FLUID, AND PLASMA
    SUN, AH
    PARNES, LS
    FREEMAN, DJ
    [J]. JOURNAL OF OTOLARYNGOLOGY, 1995, 24 (02): : 134 - 137
  • [9] PHARMACOKINETICS OF FENTANYL IN CEREBROSPINAL-FLUID, PLASMA AND URINE OF DOGS
    HUG, CC
    MURPHY, MR
    [J]. FEDERATION PROCEEDINGS, 1977, 36 (03) : 1000 - 1000
  • [10] CLINICAL PHARMACOKINETICS OF CEREBROSPINAL-FLUID
    BONATI, M
    KANTO, J
    TOGNONI, G
    [J]. CLINICAL PHARMACOKINETICS, 1982, 7 (04) : 312 - 335